Long term outcomes of stereotactic MR-guided adaptive radiotherapy for prostate cancer

被引：0
|
作者：
van Vliet, Claire [1 ]
Meijnen, Philip [1 ]
Piet, Anna H. M. [1 ]
Cobussen, Paul [1 ]
Slotman, Berend J. [1 ]
van Moorselaar, Reindert J. A. [2 ]
Bruynzeel, Anna M. E. [1 ]
机构：
[1] Vrije Univ Amsterdam, Amsterdam UMC Locat, Radiat Oncol, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Amsterdam UMC Locat, Urol, Amsterdam, Netherlands
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 194卷
关键词：
Prostate cancer; SMART; MR-guided radiotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2536
引用
收藏
页码：S2546 / S2548
页数：4
相关论文
共 50 条
  • [21] Necessity of Plan Adaptation in Stereotactic MR-Guided Online Adaptive Radiotherapy
    Williams, C. L.
    Han, Z.
    Huynh, M.
    Leeman, J. E.
    Singer, L.
    Cagney, D. N.
    Mak, R. H.
    Huynh, E.
    MEDICAL PHYSICS, 2021, 48 (06)
  • [22] Clinical Outcomes of Prostate SBRT Using Non-adaptive MR-Guided Radiotherapy
    Sandoval, Maria L.
    Rishi, Anupam
    Latifi, Kujtim
    Grass, G. Daniel
    Torres-Roca, Javier
    Rosenberg, Stephen A.
    Yamoah, Kosj
    Johnstone, Peter A. S.
    CANCER CONTROL, 2024, 31
  • [23] Efficacy of an Adaptive Plan Quality Predictor for Decision Support in Online MR-Guided Adaptive Radiotherapy for Prostate Stereotactic Ablative Radiotherapy
    Wang, S.
    Maniscalco, A.
    Su, F. C.
    Liang, X.
    Washington, B.
    Kabat, C.
    Garant, A.
    Desai, N. B.
    Pompos, A.
    Hannan, R.
    Yang, D. X.
    Nguyen, D.
    Lin, M. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E595 - E595
  • [24] MR-guided adaptive versus CT-guided stereotactic radiotherapy for prostate cancer: Where is the best cost-benefit balance?
    Castelluccia, A.
    Marchesano, D.
    Grimaldi, G.
    Annessi, I
    Bianciardi, F.
    Di Palma, A.
    Valentino, M.
    Verna, L.
    Confaloni, V
    Rea, F.
    Tolu, B.
    Borrazzo, C.
    Rago, M.
    Masi, M.
    El Gawhary, R.
    Gentile, P. C.
    EUROPEAN UROLOGY, 2022, 81 : S1412 - S1412
  • [25] Feasibility of MR-guided stereotactic body radiotherapy in 5, 2 or 1 fractions for prostate cancer
    Mohajer, J.
    Dunlop, A.
    Mitchell, A.
    Nill, S.
    Oelfke, U.
    Tree, A.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S290 - S290
  • [26] Long-Term Clinical Results of MR-Guided Stereotactic Body Radiotherapy of Liver Metastases
    Weykamp, Fabian
    Hoegen, Philipp
    Regnery, Sebastian
    Katsigiannopulos, Efthimios
    Renkamp, C. Katharina
    Lang, Kristin
    Koenig, Laila
    Sandrini, Elisabetta
    Meixner, Eva
    Rippke, Carolin
    Buchele, Carolin
    Liermann, Jakob
    Debus, Juergen
    Klueter, Sebastian
    Hoerner-Rieber, Juliane
    CANCERS, 2023, 15 (10)
  • [27] Daily dosimetric variation between image-guided volumetric modulated arc radiotherapy and MR-guided daily adaptive radiotherapy for prostate cancer stereotactic body radiotherapy
    Nicosia, Luca
    Sicignano, Gianluisa
    Rigo, Michele
    Figlia, Vanessa
    Cuccia, Francesco
    De Simone, Antonio
    Giaj-Levra, Niccolo
    Mazzola, Rosario
    Naccarato, Stefania
    Ricchetti, Francesco
    Vitale, Claudio
    Ruggieri, Ruggero
    Alongi, Filippo
    ACTA ONCOLOGICA, 2021, 60 (02) : 215 - 221
  • [28] Clinical Outcomes of Prostate SBRT Using Non-Adaptive MR-Guided Radiotherapy (MRgRT)
    Sandoval, M. L.
    Youssef, I.
    Latifi, K.
    Grass, D.
    Torres-Roca, J. F.
    Rosenberg, S. A.
    Yamoah, K.
    Johnstone, P. A. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E245 - E245
  • [29] Tumor control after MR-guided adaptive stereotactic radiotherapy for adrenal metastases
    Schneiders, F.
    Van Vliet, C.
    Palacios, M. A.
    Slotman, B. J.
    Lagerwaard, F. J.
    Bruynzeel, A. M.
    Senan, S.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S35 - S36
  • [30] Feasibility of Adaptive MR-guided Stereotactic Body Radiotherapy (SBRT) of Lung Tumors
    Padgett, Kyle R.
    Simpson, Garrett N.
    Llorente, Ricardo
    Samuels, Michael A.
    Dogan, Nesrin
    CUREUS, 2018, 10 (04):
12345